Why the study?
PCAT attenuation on CTA is a credible indicator of coronary inflammation in CAD, but the long-term effects of high-dose statins on PCAT attenuation and plaque distribution required evaluation.
Does long-term high-dose statin treatment reduce pericoronary inflammation and improve plaque distribution in patients with typical chest pain and documented atheromatous plaque?
Population
52 patients with typical chest pain, low-to-intermediate likelihood of CAD, and documented atheromatous plaque
Comparison
Long-term high-dose statin treatment
Design
Prospective observational study
Follow-up
One year
Authors
Loading...
High-dose statin therapy is associated with reduced pericoronary inflammation and favorable changes in plaque morphology on coronary CTA after one year.
Does long-term high-dose statin treatment reduce pericoronary inflammation and improve plaque distribution in patients with typical chest pain and documented atheromatous plaque?
High-dose statin therapy is associated with reduced pericoronary inflammation and favorable changes in plaque morphology on coronary CTA after one year.
Matyas et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: